MYOVANT SCIENCES GMBH has a total of 29 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Argentina. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are BIO QUANT INC, RED HILL BIOPHARMA LTD and EUSTRALIS PHARMACEUTICALS LTD TRADING AS PRESSURA NEURO.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | United States | 4 | |
#3 | Argentina | 3 | |
#4 | Australia | 3 | |
#5 | Canada | 3 | |
#6 | EPO (European Patent Office) | 3 | |
#7 | Brazil | 2 | |
#8 | China | 2 | |
#9 | Mexico | 2 | |
#10 | Israel | 1 | |
#11 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Rajasekhar Vijaykumar Reddy | 22 |
#2 | Johnson Brendan Mark | 22 |
#3 | Seely Lynn | 15 |
#4 | Mudd Jr Paul N | 8 |
#5 | Maclean David B | 7 |
#6 | Williams Laura Ann | 7 |
#7 | Tanimoto Masataka | 7 |
#8 | Hibberd Mark | 7 |
#9 | Wollowitz Susan | 7 |
#10 | Sukhatme Mayukh Vasant | 5 |
Publication | Filing date | Title |
---|---|---|
WO2021069700A1 | Crystalline solvated forms of n-(4-(1-(2,6-difluorobenzyl)-5- ((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4- tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-n'-methoxyurea | |
WO2021069711A1 | Crystalline forms of n-(4-(1-(2,6-difluorobenzyl)-5- ((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo- 1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-n'- methoxyurea | |
CA3038865A1 | Methods of treating female infertility | |
AU2017336363A1 | Methods of treating uterine fibroids and endometriosis | |
MX2019003733A | Treatment of prostate cancer. |